NE

Neurones SAFRA Neurones Stock Report

Last reporting period 30 Jun, 2024

Updated 22 Oct, 2024

Last price

Market cap $B

1.173

Small

Exchange

XFRA - Deutsche Boerse AG

NE9.F Stock Analysis

NE

Avoid

Based on Eyestock quantitative analysis, NE9.F`s fundamental data and valuation indicate an investment grade of Avoid at the current time.

Rating

To assess the quality of a company's business, we have collected all financial data from the statements and presented them in the form of a single number - the company's rating. Rating value of 100 is the threshold for determining a viable investment.

102/100

High score

Upside

To determine whether the current price is a reasonable to buy a stock, we compare it to our estimate of fair value. The more undervalued a stock is, the higher the upside.

-13.3 %

Greatly overvalued

Market cap $B

1.173

Dividend yield

5.09 %

Shares outstanding

24.228 B

Neurones SA engages in the provision of consulting and digital services. The company is headquartered in Nanterre, Ile-De-France. The company went IPO on 2000-05-23. The company operates within three areas: consulting, integration of technological solutions and outsourcing of information systems. The business lines are organized into three centers: Infrastructures Business, Consulting Business and Applications Business. Within the Infrastructures area, the Company provides design, integration and operation of system and networks, service desk, production engineering services, as well as remote servers and application operations and asset management consulting. As per the Applications business line, Neurones SA offers analysis, expertise and software development as well as support and third-party application maintenance. Consulting business line provides development, maintenance of applications, trainings, among others. The firm operates through several subsidiaries, including Axones SAS, Arondor, AS Delivery, AS International and Edugroupe.

View Section: Eyestock Rating